Gilead Sciences (GILD)

EBITDA

-$9.31B

Quarterly · Period ending: · USD

GILD logo

GILD EBITDA

Latest reported-$9.31B
GILD Quarterly EBITDA ($100.00K → -$9.31B)
High-resolution chart · PNG

GILD ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Gilead Sciences EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
-30,287,000
-22,357,000
-15,330,000
-18,231,000
-2,551,000
-1,558,000
-6,700,000
-23,400,000
-9,308,000
-13,560,000
-19,600,000
-13,000,000
-19,100,000
-11,500,000
-16,700,000
-14,300,000
-700,000
-11,100,000
-11,500,000
6,300,000
-14,100,000
-12,200,000
-8,800,000
-7,900,000
-8,900,000
-6,400,000
-7,000,000
-7,200,000
-8,300,000
-6,700,000
-6,100,000
-5,300,000
-6,500,000
-4,100,000
-3,300,000
-2,400,000
-7,200,000
500,000
200,000
200,000
-4,900,000
100,000
100,000
100,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.